deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT00791258

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure (BP CRUSH)

A Prospective, Open-Label, Titration Study to Evaluate the Efficacy and Safety Safety of AZOR in Multiple Subgroups of Hypertensive Subjects Who Are Non-Responders to Anti-Hypertensive Monotherapy

Sponsor: Daiichi Sankyo

Conditions Hypertension
Updated 10 times since 2017 Last updated: Dec 20, 2018 Started: Nov 30, 2008 Primary completion: Aug 31, 2009 Completion: Sep 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00791258, this PHASE4 trial focuses on Hypertension and remains completed. Sponsored by Daiichi Sankyo, it has been updated 10 times since 2008, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshotCompleted~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotCompleted~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2024 · 38 months · monthly snapshotCompleted~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Mar 2024 [monthly]

    Completed PHASE4

Show 5 earlier versions
  1. Feb 2019 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jun 2018 — Feb 2019 [monthly]

    Completed PHASE4

  3. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE4

  4. Feb 2017 — Sep 2017 [monthly]

    Completed PHASE4

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Daiichi Sankyo
  • Integrium
Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .